Smoking cessation devices, methods of use and methods of conducting business therewith

Abstract

The present invention provides several smoking and tobacco use cessation devices and methods which entirely eliminate the requirement of ignition and burning of substances which emit harmful substances and vapors while simultaneously providing therapeutically efficacious amounts of nicotine and/or nicotine substitutes, and optionally tobacco aroma and taste and/or other undesirable habit inhibiting compounds and antagonists and other desirable orally ingestible substances.

1 . An orally deployable tobacco smoking cessation means adapted for use in a fitting relationship with a tobacco smoking device, and comprising a substance effective to act upon and/or activate nicotine receptors in a user thereof.  
   
   
       2 . The deployable means of  claim 1  wherein said substance is present in an amount to at least in part satiate a user's need for nicotine.  
   
   
       3 . The deployable means of  claim 1  wherein said substance is selected from the group consisting of nicotine and nicotine substitutes.  
   
   
       4 . The deployable means of  claim 1  which is composed of a mouth tissue-dissolvable substance.  
   
   
       5 . The deployable means of  claim 1 , wherein said means comprises the shape of a mouthpiece means adapted for use with tobacco smoking devices.  
   
   
       6 . The deployable means of  claim 5 , wherein said means comprises a preform in the shape of a mouthpiece means adapted for use with tobacco smoking devices, and wherein said preform is coated with a mouth tissue dissolvable substance which comprises a substance effective to act upon and/or activate nicotine receptors in a user thereof.  
   
   
       7 . The deployable means of  claim 1  which further comprises a flavor means.  
   
   
       8 . The deployable means of  claim 1  which further comprises a substance effective to act as an antagonist to substances and/or acts associated with behavior deemed undesirable by the user of the deployable means, and/or which said user is attempting to avoid.  
   
   
       9 . The deployable means of  claim 8  wherein said antagonist is at least in part effective to inhibit the user's desire and/or affect the user's intake of opiates, alcohol, and participation in gambling activities.  
   
   
       10 . The deployable means of  claim 9  wherein said antagonist is selected from the group consisting of naltrexone, naloxone and derivatives thereof.  
   
   
       11 . The deployable means of  claim 1  wherein said means comprises a hard candy mouth tissue dissolvable substance, which further comprises a substance effective to act on and/or activate nicotine receptors in the user thereof.  
   
   
       12 . The deployable means of  claim 3  wherein said substance is selected from the group consisting of levo nicotine, dextro nicotine, recemic mixtures thereof, pharmaceutically acceptable salt forms of nicotine, including dihydrochloride, sulfate, bitartrate, salicylate, hydrogen tartrate and hemisulfate forms, and all known analogs thereof and mixtures thereof.  
   
   
       13 . The deployable means of  claim 1  further comprising an orally deployable and/or ingestible substance effective to at least in part satisfy an end result desired by the user.  
   
   
       14 . The deployable means of  claim 13  wherein said orally deployable and/or ingestible substance is selected from the group consisting of pharmaceutically active substances including Prozac and its generic forms, antidepressants, anti-psychotics, Wellbutrin and its generic forms, cholesterol lowering drugs including the statin family drugs, anti-viral compounds, anti-bacterial compounds, anti-infective compounds, anti-fungal compounds, vaccines, antacid compounds, anti-hypertension compounds, anti-cancer compounds, skin color enhancers, prophylactics, birth control, caffeine, aspirin, weight reduction aids, appetite suppressors, weight increasing aids, cold medication, breath enhancers, neutraceuticals, dietary supplements, sleeping aids, anticoagulants, vitamins, energy boosting compounds, complexion aids, tooth decay inhibitors, and mixtures thereof.  
   
   
       15 . The deployable means of  claim 1  further comprising indicating means effective for indicating the presence of available substance effective to act upon and/or activate nicotine receptors in a user thereof.  
   
   
       16 . The deployable means of  claim 1  further comprising indicating means effective for simulating the indication of the presence of available substance effective to act upon and/or activate nicotine receptors in a user thereof.  
   
   
       17 . A simulated tobacco smoking device generally comprising the dimensions and appearance of a cigarette or cigar, and adapted to form a fitting relationship with the orally deployable smoking cessation means of any of claims  1 ,  2 ,  3 ,  4 ,  5 ,  6 ,  7 ,  8 ,  9 ,  10 ,  11 ,  12 ,  1 . 3 ,  14 ,  15 , and  16   
   
   
       18 . The simulated tobacco smoking device of  claim 17  further comprising a feature selected from the group consisting of a fragrance, color scheme, flavoring, advertisements, messages, graphics and a circumferentially protruding ring or lip surrounding a portion near the orally deployable end of the device.  
   
   
       19 . The simulated tobacco smoking device of  claim 17  further comprising a substance effective to act upon and/or activate nicotine receptors in the user thereof.  
   
   
       20 . The simulated tobacco smoking device of  claim 17  further comprising a substance effective to act as an antagonist and which is at least in part effective to inhibit a user's desire and/or affect the user's intake of opiates, alcohol, and participation in gambling activities.  
   
   
       21 . The simulated tobacco smoking device of  claim 19  wherein said antagonist is selected from the group consisting of naltrexone, naloxone, and derivatives thereof.  
   
   
       22 . The simulated tobacco smoking device of  claim 17  further comprising an orally deployable and/or ingestible substance effective to at least in part satisfy an end result desired by the user thereof.  
   
   
       23 . The simulated tobacco smoking device of  claim 22  wherein said substance is selected from the group consisting of pharmaceutically active substances including Prozac and its generic forms, anti-depressants, anti-psychotics, Wellbutrin and its generic forms, cholesterol lowering drugs including the statin family of drugs, anti-viral compounds, anti-bacterial compounds, anti-infective compounds, anti-fungal compounds, vaccines, antacid compounds, anti-hypertension compounds, anti-cancer compounds, skin color enhancers, prophylactics, birth control compounds, caffeine, aspirin, weight reduction aids, appetite suppressors, weight increasing aids, cold medication, breath enhancers, neutraceuticals, dietary supplements, sleeping aids, anticoagulants, vitamins, energy boosting compounds, complexion aids, tooth decay inhibitors, and mixtures thereof.  
   
   
       24 . A container means comprising a plurality of the simulated tobacco smoking device of  claim 17 .  
   
   
       25 . The container means of  claim 24  further comprising a plurality of the orally deployable smoking cessation means of claims  1 ,  2 ,  3 ,  4 ,  5 ,  6 ,  7 ,  8 ,  9 ,  10 ,  11 , 12 , 13 ,  14 , 15 , and  16 .  
   
   
       26 . A tobacco smoking cessation means comprising an elongated tube comprising a first end and an orally deployable second end, and which further comprises a heating means in a position contiguous or substantially juxtaposed to the first end which is effective to undergo an exothermic reaction to liberate heat, a longitudinally disposed air passageway surrounding at least a portion of said heating means and in communication with said first and second ends, and a source of tobacco or tobacco substitute situated therein, such that upon activation of said heat generating means to liberate heat a user may orally draw air from the first end through the elongated tube past the heat generating means through the source of tobacco to orally receive heated air comprising tobacco aroma and/or taste.  
   
   
       27 . The smoking cessation means of  claim 26  which is generally of the shape and weight of a cigarette or cigar.  
   
   
       28 . The smoking cessation means of  claim 26  further comprising a person satisfying amount of a substance effective to act upon and/or activate nicotine receptors in a user thereof.  
   
   
       29 . The smoking cessation means of  claim 28  wherein said substance is selected from the group consisting of nicotine and nicotine substitutes.  
   
   
       30 . The smoking cessation means of  claim 28  further comprising a substance effective to act as an antagonist which at least in part is effective to inhibit a user's desire and/or affect the user's intake of opiates, alcohol and participation in gambling activities.  
   
   
       31 . The smoking cessation means of  claim 30  wherein said substance is selected from the group consisting of naltexone, naloxone and derivatives thereof.  
   
   
       32 . The smoking cessation means of  claim 28  further comprising an orally deployable and/or ingestible substance effective to at least in part satisfy an end result desired by the user.  
   
   
       33 . The smoking cessation means of  claim 32  wherein said orally deployable and/or ingestible substance is selected from the group consisting of pharmaceutically active substances including Prozac and its generic forms, anti-depressants, anti-psychotics, Wellbutrin and its generic forms, cholesterol lowering drugs including the statin family of drugs, anti-viral compounds, anti-bacterial compounds, anti-infective compounds, anti-fungal compounds, vaccines, antacid compounds, anti-hypertension compounds, anti-cancer compounds, skin color enhancers, prophylactics, birth control compounds, caffeine, aspirin, weight reduction aids, appetite suppressors, weight increasing aids, cold medication, breath enhancers, neutraceuticals, dietary supplements, sleeping aids, anti-coagulants, vitamins, energy boosting compounds, complexion aids, tooth decay inhibitors, and mixtures thereof.  
   
   
       34 . The smoking cessation means of  claim 28  further comprising a feature selected from the group consisting of a fragrance, color scheme, flavoring, advertisements, messages, graphics and a circumferentially protruding ring or lip surrounding a portion near the orally deployable end of the means.  
   
   
       35 . A container means comprising a plurality of the smoking cessation means of  claim 28 .  
   
   
       36 . The container means of  claim 35  further comprising a plurality of the orally deployable smoking cessation means of claims  1 ,  2 ,  3 ,  4 ,  5 ,  6 ,  7 ,  8 ,  9 ,  10 ,  11 ,  12 ,  13 ,  14 ,  15 , and  16 .  
   
   
       37 . A method of conducting business comprising activities selected from the group consisting of manufacturing, having manufactured, advertising, offering for sale, selling, distributing and licensing an orally deployable tobacco smoking cessation means of  claim 1 .  
   
   
       38 . A method of conducting business comprising activities selected from the group consisting of manufacturing, having manufactured, advertising, offering for sale, selling, distributing, and licensing a simulated tobacco smoking device of  claim 17 .  
   
   
       39 . A method of conducting business comprising activities selected from the group consisting of manufacturing, having manufactured, advertising, offering for sale, selling, distributing, and licensing a smoking cessation means of  claim 28.